Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 1
Chemotherapy Induced Pain Global
Clinical Trials Review, H1, 2014
Reference Code: GDHC2044CTIDB
Publication Date: MAR 2014
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 2
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 4
Introduction ......................................................................................................................................................................................... 5
Chemotherapy Induced Pain .......................................................................................................................................................... 5
Report Guidance ............................................................................................................................................................................. 5
Clinical Trials by Region ..................................................................................................................................................................... 6
Clinical Trials and Average Enrollment by Country ......................................................................................................................... 7
Top Countries Contributing to Clinical Trials in Asia-Pacific ........................................................................................................ 9
Top Countries Contributing to Clinical Trials in Europe ............................................................................................................. 10
Top Countries Contributing to Clinical Trials in North America .................................................................................................. 11
Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials .......................................... 12
Clinical Trials by Phase in G7 Countries .......................................................................................................................................... 13
Clinical Trials in G7 Countries by Trial Status .................................................................................................................................. 14
Clinical Trials by Phase .................................................................................................................................................................... 15
In Progress Trials by Phase .......................................................................................................................................................... 16
Clinical Trials by Trial Status ............................................................................................................................................................ 17
Subjects Recruited Over a Period of Time ....................................................................................................................................... 18
Clinical Trials by Sponsor Type ........................................................................................................................................................ 19
Prominent Sponsors ......................................................................................................................................................................... 20
Top Companies Participating in Chemotherapy Induced Pain Therapeutics Clinical Trials .......................................................... 21
Prominent Drugs .............................................................................................................................................................................. 22
Clinical Trial Profiles ......................................................................................................................................................................... 23
Clinical Trial Overview of Top Companies .................................................................................................................................... 23
NEMA Research Inc. ................................................................................................................................................................. 23
Clinical Trial Overview of NEMA Research Inc. ........................................................................................................................ 23
CK Life Sciences Int'l., (Holdings) Inc. ...................................................................................................................................... 23
Clinical Trial Overview of CK Life Sciences Int'l., (Holdings) Inc. .............................................................................................. 23
Amgen Inc. ................................................................................................................................................................................ 23
Clinical Trial Overview of Amgen Inc. ........................................................................................................................................ 23
Clinical Trial Overview of Top Institutes / Government ................................................................................................................. 24
The University of Texas M. D. Anderson Cancer Center........................................................................................................... 24
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center .................................................................. 24
University of the Sunshine Coast .............................................................................................................................................. 25
Clinical Trial Overview of University of the Sunshine Coast ...................................................................................................... 25
Danish University of Pharmaceutical Sciences ......................................................................................................................... 26
Clinical Trial Overview of Danish University of Pharmaceutical Sciences ................................................................................. 26
The Royal Marsden NHS Foundation Trust .............................................................................................................................. 27
Clinical Trial Overview of The Royal Marsden NHS Foundation Trust ...................................................................................... 27
New Mexico Cancer Care Alliance ............................................................................................................................................ 28
Clinical Trial Overview of New Mexico Cancer Care Alliance .................................................................................................... 28
Virginia Commonwealth University ............................................................................................................................................ 29
Clinical Trial Overview of Virginia Commonwealth University ................................................................................................... 29
Capital District Health Authority, Canada .................................................................................................................................. 30
Clinical Trial Overview of Capital District Health Authority, Canada .......................................................................................... 30
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 3
Massachusetts General Hospital ............................................................................................................................................... 31
Clinical Trial Overview of Massachusetts General Hospital ...................................................................................................... 31
Five Key Clinical Profiles .................................................................................................................................................................. 32
Appendix .......................................................................................................................................................................................... 54
Abbreviations ................................................................................................................................................................................ 54
Definitions ..................................................................................................................................................................................... 54
Research Methodology ................................................................................................................................................................. 55
Secondary Research .................................................................................................................................................................... 55
About GlobalData ......................................................................................................................................................................... 56
Disclaimer ..................................................................................................................................................................................... 56
Source .......................................................................................................................................................................................... 56
List of Tables
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region, 2014* ........................................................................ 6
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* ...................... 7
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* .......................................... 8
Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* .......................................................... 9
Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* ............................................................... 10
Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* .................................................... 11
Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials, G7 Countries (%), 2014* ................................................... 12
Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* ............................................................. 13
Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* ..................................................... 14
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase, 2014* ........................................................................ 15
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* ..................................................... 16
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* ................................................................ 17
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 ........................ 18
Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* ................................................ 19
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* ................................................................ 20
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* ............................................. 21
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* .................. 22
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by NEMA Research Inc., 2014* .............. 23
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by CK Life Sciences Int'l., (Holdings) Inc.,
2014* ................................................................................................................................................................................................ 23
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*.............................. 23
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson
Cancer Center, 2014* ....................................................................................................................................................................... 24
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Sunshine Coast, 2014*
......................................................................................................................................................................................................... 25
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish University of Pharmaceutical
Sciences, 2014* ............................................................................................................................................................................... 26
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Marsden NHS Foundation
Trust, 2014* ...................................................................................................................................................................................... 27
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by New Mexico Cancer Care Alliance,
2014* ................................................................................................................................................................................................ 28
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University,
2014* ................................................................................................................................................................................................ 29
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 4
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority,
Canada, 2014* ................................................................................................................................................................................. 30
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
......................................................................................................................................................................................................... 31
List of Figures
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* .................................................................. 6
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* ...................... 7
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* .......................................... 8
Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* ........................................................ 10
Chemotherapy Induced Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* ............................................. 11
Proportion of Chemotherapy Induced Pain to Oncology Clinical Trials, G7 Countries (%), 2014* ................................................... 12
Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* ............................................................. 13
Chemotherapy Induced Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* ..................................................... 14
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* ................................................................. 15
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* ................................................................................................... 16
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* ................................................................ 17
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 ........................ 18
Chemotherapy Induced Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* ......................................... 19
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* ............................................................... 20
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* ............................................ 21
Chemotherapy Induced Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* ................. 22
GlobalData Methodology .................................................................................................................................................................. 55
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 5
Introduction
Chemotherapy Induced Pain
Chemotherapy induced pain is most often a form of nerve pain. It can cause peripheral neuropathy (painful numbness of the extremities), or paresthesia (numbness and tingling of hands, feet or any extremity of the body).
Report Guidance
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 outlines clinical trials in Chemotherapy Induced
Pain. The prominent features of this report are -
1. Comprehensive data related to Chemotherapy Induced Pain clinical trials by region, country, phase, and
recruitment status
2. Clinical trials conducted by key Companies and Institutes. The selection of the sponsors is based on the total
number of Chemotherapy Induced Pain clinical trials conducted
3. Prominent drugs are provided based on number of ongoing clinical trials
4. The trials compiled in this report are from clinical trial registries, conferences, journals etc
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 6
Clinical Trials by Region
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region (%), 2014*
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
Chemotherapy Induced Pain Therapeutics, Global, Clinical Trials by Region, 2014*
World Zones Number of Clinical Trials
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 9
Top Countries Contributing to Clinical Trials in Asia-Pacific
Chemotherapy Induced Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
Country Name Number of Clinical Trials
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 10
Top Countries Contributing to Clinical Trials in Europe
Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
Chemotherapy Induced Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014*
Country Name Number of Clinical Trials
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 23
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
NEMA Research Inc.
Clinical Trial Overview of NEMA Research Inc.
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by NEMA Research Inc., 2014*
Trial Title Stage of Development Status
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
CK Life Sciences Int'l., (Holdings) Inc.
Clinical Trial Overview of CK Life Sciences Int'l., (Holdings) Inc.
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by CK Life Sciences Int'l.,
(Holdings) Inc., 2014*
Trial Title Stage of Development Status
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Chemotherapy Induced Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
Trial Title Stage of Development Status
Source: GlobalData’s Pharma eTrack Clinical Trials Database
(*)Trials are taken for a time period of 1982 - 2014
2014 trials are taken as of March 2014
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 54
Appendix
Abbreviations
BRIC: Brazil, Russia, India and China
NCI: National Cancer Institute
Definitions
PHASE I TRIALS: Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the
side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy
participants and/or patients.
PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular
indication or indications in patients with the disease or condition under study and to determine the common short-term
side effects and risks.
PHASE III TRIALS: Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness
of the drug has been obtained, and were intended to gather additional information to evaluate the overall benefit-risk
relationship of the drug and provide an adequate basis for physician labeling.
PHASE IV TRIALS: Post-marketing studies to delineate additional information including the drug's risks, benefits,
and optimal use.
TRIAL STATUS: Indicates the current stage of a trial, whether it is planned, ongoing, or completed. Possible values
include:
Trial in Progress: This is inclusive of;
Planned: participants were not yet being recruited or enrolled
Recruiting: participants were currently being recruited and enrolled
Enrolling by invitation: participants were being (or will be) selected from a predetermined population
Active, not recruiting: study is ongoing (i.e., patients were being treated or examined), but enrollment has
completed
Completed: the study has concluded normally; participants were no longer being examined or treated (i.e.,
last patient's last visit has occurred)
Suspended: recruiting or enrolling participants has halted prematurely but potentially will resume
Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants were
no longer being examined or treated
Withdrawn: study halted prematurely, prior to enrollment of first participant
SUBJECTS RECRUITED: The number of patients so enrolled for the trial in concern, to be analyzed.
UNACCOMPLISHED TRIALS: The category comprising of the terminated, withdrawn and suspended trials.
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 55
Research Methodology
GlobalData dedicated Research and Analysis Teams consists of experienced professionals with a pedigree in
marketing, market research and consulting in the pharmaceutical industry with advanced statistical expertise.
GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk) and the Society of
Competitive Intelligence Professionals (www.scip.org).
All GlobalData databases were continuously updated and revised. The following research methodology is followed for
all databases and reports.
GlobalData Methodology
Data extraction from Pharma eTrack
Data Analysis
Self QC
Quality check by QC Lead
Submission of the Report
Data Validation
Source: GlobalData
Secondary Research
The research process begins with exhaustive secondary research on internal and external sources being carried out
to source qualitative and quantitative information relating to each market.
The secondary research sources that were typically referred to include, but were not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC Filings;
Industry trade journals, scientific journals and other technical literature;
Internal and external proprietary databases;
Relevant patent and regulatory databases;
National government documents, statistical databases and market reports;
Procedure registries; and
News articles, press releases and web-casts specific to the companies operating in the market.
SAMPLE
Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014
GDHC2044CTIDB / Published MAR 2014
© GlobalData. This report is a licensed product and is not to be photocopied
Page 56
About GlobalData
We hope that the data and analysis in this brief will help you make informed and imaginative business decisions. If
you have further requirements, GlobalData consulting team may be able to help you. GlobalData offers Tailor made
analytical and advisory services to drive your key strategic decisions.
Disclaimer
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher,
GlobalData.
Source
http://www.cancer.org/acs/groups/content/@nho/documents/document/globalfactsandfigures2007rev2p.pdf
http://clinicaltrials.gov/
http://www.cancer.org/
http://www.asco.org/
http://www.pharmaetrack.com/
http://www.medpedia.com/
https://www.goldbamboo.com/pictures-t1192.html
http://www.clinicalconnection.com/
http://www.trialscentral.org/
http://www.thefreelibrary.com/
http://dailymed.nlm.nih.gov/dailymed/about.cfm
http://www.nextbio.com/b/nextbio.nb
http://www.controlled-trials.com/isrctn/search.html
http://www.anzctr.org.au/trialSearch.aspx
http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=72377
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=search&action=input&language=E